Share

Biohaven Pharmaceuticals CEO on how Nurtec migraine drug punches above its weight

Biohaven Pharmaceuticals CEO Vlad Coric said the company's digital-first and patient-focused strategy is giving it an edge against competitors in marketing the migraine drug Nurtec.
02:01
Mon, Mar 22 20217:18 PM EDT